Morgan Stanley Ani Pharmaceuticals Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Morgan Stanley holds 200,876 shares of ANIP stock, worth $19.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200,876

Previous 437,453 54.08%

Holding current value

$19.1 Million

Previous $29.3 Million 55.25%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$57.79 - $72.95 $13.7 Million - $17.3 Million	-236,577 Reduced 54.08%	200,876 $13.1 Million
Q1 2025 May 15, 2025	BUY	$53.93 - $68.36 $11.4 Million - $14.4 Million	210,875 Added 93.07%	437,453 $29.3 Million
Q4 2024 Feb 14, 2025	SELL	$53.35 - $61.74 $9.32 Million - $10.8 Million	-174,751 Reduced 43.54%	226,578 $12.5 Million
Q3 2024 May 14, 2025	BUY	$54.33 - $65.72 $7.12 Million - $8.61 Million	130,990 Added 48.45%	401,329 $23.9 Million
Q3 2024 Nov 14, 2024	BUY	$54.33 - $65.72 $7.12 Million - $8.61 Million	130,990 Added 48.45%	401,329 $23.9 Million
Q2 2024 May 14, 2025	BUY	$58.53 - $68.82 $2.56 Million - $3.01 Million	43,761 Added 19.31%	270,339 $17.2 Million
Q2 2024 Oct 17, 2024	BUY	$58.53 - $68.82 $1.06 Million - $1.24 Million	18,079 Added 7.17%	270,339 $17.2 Million
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $1.06 Million - $1.24 Million	18,079 Added 7.17%	270,339 $17.2 Million
Q1 2024 Oct 17, 2024	SELL	$54.2 - $69.69 $979,881 - $1.26 Million	-18,079 Reduced 6.69%	252,260 $17.4 Million
Q1 2024 Aug 16, 2024	BUY	$54.2 - $69.69 $1.1 Million - $1.42 Million	20,317 Added 8.76%	252,260 $17.4 Million
Q1 2024 May 15, 2024	BUY	$54.2 - $69.69 $1.1 Million - $1.42 Million	20,317 Added 8.76%	252,260 $17.4 Million
Q4 2023 Aug 16, 2024	SELL	$48.72 - $65.43 $1.87 Million - $2.51 Million	-38,396 Reduced 14.2%	231,943 $12.8 Million
Q4 2023 Feb 13, 2024	BUY	$48.72 - $65.43 $598,768 - $804,134	12,290 Added 5.6%	231,943 $12.8 Million
Q3 2023 Nov 15, 2023	BUY	$50.28 - $64.61 $1.9 Million - $2.44 Million	37,820 Added 20.8%	219,653 $12.8 Million
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $2.9 Million - $4.18 Million	77,692 Added 74.6%	181,833 $9.79 Million
Q1 2023 May 15, 2023	BUY	$37.61 - $45.72 $110,159 - $133,913	2,929 Added 2.89%	104,141 $4.14 Million
Q4 2022 Feb 14, 2023	SELL	$31.9 - $41.95 $626,675 - $824,107	-19,645 Reduced 16.25%	101,212 $4.07 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $158,785 - $202,327	5,323 Added 4.61%	120,857 $3.88 Million
Q2 2022 Oct 27, 2022	BUY	$23.09 - $33.46 $1.6 Million - $2.32 Million	69,280 Added 149.78%	115,534 $3.43 Million
Q2 2022 Aug 15, 2022	BUY	$23.09 - $33.46 $1.6 Million - $2.32 Million	69,280 Added 149.78%	115,534 $3.43 Million
Q1 2022 Oct 27, 2022	SELL	$26.91 - $47.15 $1.86 Million - $3.27 Million	-69,280 Reduced 59.97%	46,254 $1.3 Million
Q1 2022 May 13, 2022	BUY	$26.91 - $47.15 $87,511 - $153,331	3,252 Added 7.56%	46,254 $1.3 Million
Q4 2021 Feb 14, 2022	SELL	$32.97 - $56.85 $1.78 Million - $3.07 Million	-53,940 Reduced 55.64%	43,002 $1.98 Million
Q3 2021 Nov 15, 2021	BUY	$26.48 - $35.99 $2.57 Million - $3.49 Million	96,942 New	96,942 $3.18 Million

Others Institutions Holding ANIP

# of Institutions

243

Shares Held

20M

Call Options Held

19.9K

Put Options Held

12.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.66B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account